Skip to content

Use of Infrared Spectroscopy in Septic Arthritis Diagnosis

Use of Infrared Spectroscopy in Septic Arthritis Diagnosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02860871
Acronym
SynoFAST
Enrollment
611
Registered
2016-08-09
Start date
2014-06-30
Completion date
2016-12-31
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Effusion

Brief summary

The main objective of this study is to assess the ability of Fiber-optic Evanescent Wave Spectroscopy (FEWS) to discriminate synovial fluids samples of septic arthritis patients from other causes of joint effusion by analyzing ex vivo joint fluid samples collected during routine clinical care.

Interventions

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients benefiting from joint fluid puncture for diagnostic purposes in the rheumatology hospitals participating in the study * patients over 18 year old, * patients who received information about the protocol and have not expressed opposition to participate.

Exclusion criteria

* patients opposing the study, * patients aged below 18 year old * Protected major (safeguard justice , trusteeship and guardianship) and persons deprived of liberty

Design outcomes

Primary

MeasureTime frameDescription
Diagnosis of the cause of joint effusionthrough study completion, an average of 6 monthsThe final diagnosis of the cause of joint effusion is made by the clinician based on the clinical and laboratory data : septic arthritis or other causes of arthritis.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026